U.S. stock futures steady ahead of Fed decision; Powell, General Mills eyed
Investing.com -- Centene Corporation (NYSE:CNC) stock rose 4% in pre-market trading Thursday after the healthcare company reaffirmed its 2025 earnings guidance that exceeds analyst expectations.
The company confirmed it remains on track to deliver approximately $1.75 in adjusted diluted earnings per share for the full year 2025, significantly above the consensus estimate of $1.64 per share. Management made this announcement ahead of their scheduled participation at the Deutsche Bank 2025 Healthcare Summit.
Centene indicated that its business and financial results through August are consistent with the previously-issued forecast, providing investors with confidence in the company’s ability to meet its financial targets for the year.
The healthcare insurer is set to present at the Deutsche Bank summit on Thursday, September 11, 2025, at 8:00 a.m. EDT, where management will discuss the company’s performance and outlook in more detail.
Today’s stock movement reflects investor confidence in Centene’s financial outlook and operational execution as the company continues to outperform analyst expectations for the fiscal year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.